| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director +2 more
43 companies
Ra Capital Management, L.P. is a Director, 10% Owner at WVE with holdings across 43 companies. Recent SEC Form 4 filings include 23 buys and 0 sells.
Estimated insider holdings value: $3513.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2022 | CTKB Cytek Biosciences, Inc. | Director | Buy | 647,264 | $12.74 | $8,248,254.64 | +1.8% | -17.1% | -24.2% | |
| Mar 2, 2022 | CTKB Cytek Biosciences, Inc. | Director | Buy | 441,865 | $12.95 | $5,721,950.62 | +1.3% | -26.5% | -27.0% | |
| Feb 25, 2022 | CTKB Cytek Biosciences, Inc. | Director | Buy | 420,380 | $13.23 | $5,559,664.42 | +1.3% | -26.7% | -15.8% | |
| Feb 22, 2022 | CTKB Cytek Biosciences, Inc. | Director | Buy | 547,380 | $14.06 | $7,695,707.30 | +1.8% | -25.3% | -16.4% | |
| Feb 16, 2022 | CTKB Cytek Biosciences, Inc. | Director | Buy | 498,629 | $14.89 | $7,426,824.59 | +1.7% | -32.6% | -21.4% | |
| Sep 17, 2021 | TYRA Tyra Biosciences, Inc. | Director, 10% Owner | Buy | 1,250,000 | $16.00 | $20,000,000.00 | +30.9% | -31.0% | -61.1% | |
| Aug 12, 2021 | CLYM Climb Bio, Inc. | Director, 10% Owner | Buy | 3,200,000 | $12.50 | $40,000,000.00 | +40.6% | -1.0% | -83.0% | |
| Jul 27, 2021 | CTKB Cytek Biosciences, Inc. | Director | Buy | 2,950,000 | $17.00 | $50,150,000.00 | +48.0% | +35.4% | -29.0% | |
| Jul 6, 2021 | ABOS Acumen Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 1,875,000 | $16.00 | $30,000,000.00 | +25.7% | -25.0% | -72.8% | |
| Jul 2, 2021 | JBIO Jade Biosciences, Inc. | Director, 10% Owner | Buy | 2,785,714 | $14.00 | $38,999,996.00 | +66.6% | +5.2% | -15.1% |